Evolus IncEOLS
Price$7.69

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $316.5M+18.9% YoYTTM through 30 Jun 2026
Net Income -$34.3MTTM through 30 Jun 2026
Free Cash Flow -$18.3MTTM through 30 Jun 2026

Margins

Current
Gross Margin66.9%
EBITDA Margin-3.1%
Operating Margin-9.4%
Net Margin-10.9%

Returns

111.1%ROE
-13.8%ROA

Balance Sheet Health

Debt / Equity-5.44x
Current Ratio2.04x
Net Debt$106.6M
Cash & Equivalents$45.2M

Quality Metrics

Altman Z-Score-1.30
Piotroski F-Score4 / 9
FCF Margin-5.8%
Rule of 40-1.4
Earnings-Beat Rate50.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $297.2M
Diluted EPS-$0.53TTM
'20'21'22'23'24'25
FY2025: $-0.80

Dividend

No dividend

Capital Allocation

Capex Intensity0.9%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.